Saturday, May 17
|
| 7:15 a.m. |
Continental Breakfast – Posters Available |
| 8 a.m. |
Welcome from the ATS President
- Irina Petrache, MD, ATSF- Professor of Medicine
|
| 8:10 a.m. |
Co-Chair Address: State of Innovation and Investment
- Sarah Spencer – Principal, EcoR1
- Craig Conoscenti, MD, ATSF – Senior Vice President, Avalyn Pharma, Inc.
|
| 8:30 a.m. |
Showcase One: Acute Respiratory Distress Syndrome
- Joe GN Garcia, MD, Founder & CEO, Aqualung Therapeutics
- Russ Lehrman, PhD, CEO, BioSuperior Technology, Inc.
- Derek W. Russell, MD, I-SPY and Quantum Leap Healthcare Collaborative
- Alan B. Dogan, MS, Scientific Officer, Recens Respiratio
- Jayakumar Rajadas, PhD, Chief Scientist - Swaza
|
| 9 a.m. |
Panel: Investor Discussion
- Moderator: Brian Matesic, Principal at Norwest Venture Partners, Norwest
- Matthew Harrison, Managing Director at Morgan Stanley
- Hal Paz, MD, Operating Partner at Khosla Ventures
- Niall O’Donnell, PhD, Managing Director at Rivervest
- I-Hung Shih, PhD, Managing Director at Eventide
|
| 9:45 a.m. |
Networking Break – Posters Available |
| 10:15 a.m. |
Showcase Two: Asthma
- Graeham Rees Douglas, PhD, Founder & CEO, Arete Medical Technologies, Ltd
- Amir A. Zeki, MD, MAS, Professor of Medicine, and InStatin CSO, InStatin
- Nello Mainolfi, PhD, Founder, President and CEO, Kymera Therapeutics
- Michael Holtzman, Founder and President, NuPeak Therapeutics
- Monica Kraft, MD, Co-Founder and Chief Medical Officer, RaeSedo, Inc
|
| 10:45 a.m. |
Payer Panel Discussion
- Moderator: Steve Flaim, PhD – Senior Special Advisor & Investor-In-Residence,
|
| 11:30 a.m. |
Showcase Three: ILD/Fibrosis
- Ryan Adams, Senior Director, aTyr Pharma
- Zhenhua Lin, BD Director, Chengdu Huitai Biomedicine Co., Ltd
- Stephen L. Huhn, MD, CMO, and SVP, Clinical Development, Contineum Therapeutics
- Anissa Kalinowski, MSc, MBA, CEO, Halo Biosciences
- Carol Satler, MD, PhD, Vice President Clinical Development, Insilico Medicine US Inc.
|
| 12 p.m. |
Lunch – Posters Available |
| 1 p.m. |
Pioneer Sponsor Address
|
| 1:15 p.m. |
Panel: Business Development
- Moderator: Mark Dowling, Head of Search & Evaluation, Immunology Business Development, Partnering, Sanofi
- Erik Bourhis, Head of Business Development, Genentech
- Nikhil Mutyal, Executive Director and Head of Search & Evaluation - AstraZeneca
- Irene Pasquali, Head of Business Development, Chiesi
- Jeremy Griggs, Head of Business Development, GSK
|
| 2 p.m. |
Showcase Four: COPD
- Irina Gitlin, VP, Research and Development, AER Therapeutics
- James Lovgren, MBA, Chief Executive Officer & Co-Founder, Aspiro Therapeutics
- Sheryl Flynn, PT, PhD, Co-Founder, CEO, Blue Marble Health
- Noel Greenberger, CEO, Nob Hill Therapeutics
- David A. Edwards, PhD, Founder, CSO, Sensory Cloud
|
| 2:30 p.m. |
Networking Break - Posters Available |
| 3 p.m. |
Showcase Five: Medical Devices
- Joshua Freedman, BSE, MSE in Bioengineering, Co-Founder & CEO, Airalux Medical
- Sterghios Moschos, CEO, PulmoBioMed Ltd
- Laura Kuett, PhD, Chief Commercial Officer, SIVA Health
- Claire Cherry, MSc, MRSC, Director of Scientific Affairs, Vitalograph
- Daniel Bollinger, Research Scientist, VosBio
|
| 3:30 p.m. |
RIS Featured Success Story
- Maria Artunduaga, MD, MPH, MTM – Founder & CEO, Samay
|
| 3:45 p.m. |
Panel: Digital Health (AI, Device and More)
- Moderator: Craig Conoscenti, MD, ATSF – Senior Vice President, Avalyn Pharma, Inc.
- Todd Austin, Executive Vice President, Global Business Development, CAIRE, Inc.
- Peter George, Senior Medical Director, Brainomix
- Peter Small, Chief Medical Officer, Hyfe
- Brian Menjivar, Director LATAM & Global Clinical Specialist, PlumOne
- Bill Bulman, Medical Director, Veracyte Inc. Medical and Clinical Affairs
|
| 4:30 p.m. |
Closing Remarks and Sponsor Recognition
- Sarah Spencer, – Principal, EcoR1
- Craig Conoscenti, MD, ATSF – Senior Vice President, Avalyn Pharma, Inc.
|
| 4:45 p.m. |
Networking Reception – Posters Available |
| 6 p.m. |
Adjourn |
